Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance NASDAQ BLPH opened at $0.04 on Friday. Bellerophon Therapeutics has a twelve month low of $0.03 and a twelve month high […]
More Stories
Craig Mason Buys 600,000 Shares of Complii FinTech Solutions Ltd (ASX:CF1) Stock
Complii FinTech Solutions Ltd (ASX:CF1 – Get Free Report) insider Craig Mason acquired 600,000 shares of the stock in a...
Skeena Resources Limited (TSE:SKE) Senior Officer Robert Jalun Kiesman Sells 2,057 Shares
Skeena Resources Limited (TSE:SKE – Get Free Report) Senior Officer Robert Jalun Kiesman sold 2,057 shares of the stock in...
Bruce K. Posey Sells 1,330 Shares of Qualys, Inc. (NASDAQ:QLYS) Stock
Qualys, Inc. (NASDAQ:QLYS – Get Free Report) insider Bruce K. Posey sold 1,330 shares of the business’s stock in a...
Andrew Mitchell Paul Purchases 38,560 Shares of Bitcoin Depot Inc. (NASDAQ:BTM) Stock
Bitcoin Depot Inc. (NASDAQ:BTM – Get Free Report) major shareholder Andrew Mitchell Paul acquired 38,560 shares of Bitcoin Depot stock...
Suzanne S. Deferie Sells 2,036 Shares of First Bancorp (NASDAQ:FBNC) Stock
First Bancorp (NASDAQ:FBNC – Get Free Report) Director Suzanne S. Deferie sold 2,036 shares of First Bancorp stock in a...
Nutrien Ltd. (NYSE:NTR) Given Average Rating of “Hold” by Analysts
Shares of Nutrien Ltd. (NYSE:NTR – Get Free Report) have been assigned a consensus recommendation of “Hold” from the nineteen...